跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 246 条关于
“revakinagene taroretcel-lwey”
全部
246
临床试验
217
药物
9
机构
0
资讯
20
5个月前
Real-World Experience with Revakinagene Taroretcel-lwey (Encelto) for MacTel: First Year Insights on Patient Selection and Surgical Technique
去年
Long-term Study Shows Sustained Benefits of NT-501 Cell Therapy for Macular Telangiectasia Type 2
2年前
FDA Extends Review of Neurotech's NT-501 for Macular Telangiectasia Type 2
去年
FDA Extends Review of Neurotech's NT-501 for Macular Telangiectasia Type 2
去年
FDA Extends Review Timeline for Neurotech's NT-501 MacTel Treatment
去年
NT-501 Shows Promise in MacTel Treatment: Pooled Data Reveals Functional and Structural Benefits
2年前
Cholinesterase Inhibitors Show Promise in Slowing Lewy Body Dementia Progression
去年
Nilotinib Shows Promise in Dementia with Lewy Bodies
去年
Cholinesterase Inhibitors Show Promise in Managing Cognitive Decline in Lewy Body Dementia
去年
B. Riley Upgrades Cognition Therapeutics to Buy Following Positive Lewy Bodies Data
第 1 页,共 2 页
上一页
下一页